SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-006895
Filing Date
2018-05-15
Accepted
2018-05-15 07:05:31
Documents
14
Period of Report
2018-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29960
2 ex99-1.htm EX-99.1 81212
3 ex99-2.htm EX-99.2 10585
4 ex99-2_001.jpg GRAPHIC 89703
5 ex99-2_002.jpg GRAPHIC 137173
6 ex99-2_003.jpg GRAPHIC 80740
7 ex99-2_004.jpg GRAPHIC 62915
8 ex99-2_005.jpg GRAPHIC 84095
9 ex99-2_006.jpg GRAPHIC 107187
10 ex99-2_007.jpg GRAPHIC 109836
11 ex99-2_008.jpg GRAPHIC 98403
12 ex99-2_009.jpg GRAPHIC 104072
13 ex99-2_010.jpg GRAPHIC 126246
14 ex99-2_011.jpg GRAPHIC 121672
  Complete submission text file 0001493152-18-006895.txt   1669409
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 18833020
SIC: 8071 Services-Medical Laboratories
Assistant Director 9